Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05315258
Title Tebentafusp in Molecular Relapsed Disease (MRD) Melanoma (TebeMRD)
Acronym TebeMRD
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Oxford
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR

Facility Status City State Zip Country Details
Cambridge University Hospitals NHS Foundation Trust (Screening only) RECRUITING Cambridge United Kingdom Details
The Beatson West of Scotland Cancer Centre RECRUITING Glasgow United Kingdom Details
The Clatterbridge Cancer Centre RECRUITING Liverpool United Kingdom Details
University College London Hospital RECRUITING London United Kingdom Details
The Christie Hospital RECRUITING Manchester United Kingdom Details
Mount Vernon Cancer Centre RECRUITING Middlesex United Kingdom Details
Newcastle upon Tyne Hospitals NHS Foundation Trust (Screening only) RECRUITING Newcastle United Kingdom Details
Churchill Hospital, Oxford University Hospitals NHS Trust RECRUITING Oxford OX3 7LE United Kingdom Details
Sheffield Teaching Hospitals NHS Foundation Trust (Screening only) RECRUITING Sheffield United Kingdom Details
University Hospital Southampton NHS Foundation Trust (Screening only) RECRUITING Southampton United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field